Polyamine analogue-mediated cell cycle responses in human melanoma cells involves the p53, p21, Rb regulatory pathway

Biochemical Society Transactions

Volumn 26, Issue 4, 1998, Pages 609-614

  Kramer, D L ^a   Vujcic, S ^a   Diegelman, P ^a   White, C ^a   Black, J D ^a   Porter, C W ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; POLYAMINE; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

APOPTOSIS; CELL CYCLE; CELL CYCLE G1 PHASE; CONFERENCE PAPER; HUMAN; HUMAN CELL; MELANOMA CELL; ONCOGENE; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 0032432509     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/bst0260609     Document Type: Conference Paper

References (25)

1. Marton, L. J. and Pegg, A. E. (1995) Am. Rev. Pharmacol. Toxicol. 35, 55-91
2. Nishioka, K. (ed.) (1996) Polyamines in cancer: Basic Mechanisms and Clinical Approaches. R. G. Landes Co., New York, NY
3. Porter, C. W., Regenass, U. and Bergeron, R. J. (1992) in Falk Symposium on Polyamines in the Gastrointestinal Tract (Dowling, R. H., Folsch, U. R. and Loser, Chr., eds), pp. 301-322, Kluwer Academic Publishers, Dordrecht
4. Casero, Jr., R. A., Celano, P., Ervin, S. J., Porter, C. W., Bergeron, R. J. and Libby, P. R. (1989) Cancer Res. 49, 3829-3833
5. Bernacki, R. J., Bergeron, R. J. and Porter, C. W. (1992) Cancer Res. 52, 2424-2430
6. Porter, C. W., Bernacki, R. J., Miller, J. and Bergeron, R. J. (1993) Cancer Res. 53, 581-586
7. DelSal, G., Loda, M. and Pagano, M. (1996) Crit. Rev. Oncogen. 7, 127-142
8. Kramer, D. L., Fogel-Petrovic, M., Miller, J., Diegelman, P., McManis, J. S., Bergeron, R. J. and Porter, C. W. (1997) Cancer Res. 57, 5521-5527
9. Kramer, D. L., Vujcic, S., Diegelman, P., Alderfer, J., Bergeron, R. J., Black, J. D. and Porter, C. W. (1998) Cancer Res., submitted
10. Agarwal, M. L., Taylor, W. R., Chernov, M. V., Chernova, O. B. and Stark, G. R. (1998) J. Biol. Chem. 273, 1-4
11. Levine, A. J. (1997) Cell 88, 323-331
12. Elledge, S. J., Winston, J. and Harper, J. W. (1992) Trends Cell Biol. 6, 388-392
13. Kastyan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B. and Craig, R. W. (1991) Cancer Res. 51, 6304-6311
14. O'Connor, P. M., Jackman, J., Bae, I., Myers, T. G., Fan, S., Mutoh, M., Scudiero, D. A., Monks, A., Sausville, E. A., Weinstein, J. N. et al. (1997) Cancer Res. 57, 4285-4300
15. Blankenberg, F. G., Storrs, R. W., Naumovski, L., Goralski, T. and Spielman, D. (1996) Blood 87, 1951-1956
16. Blankenberg, F. G., Katsikis, P. D., Storrs, R. W., Beaulieu, C., Spielman, D., Chen, J. Y., Naumovski, L. and Tait, J. F. (1997) Blood 89, 3778-3786
17. Bergeron, R. J., Feng, Y., Weimar, W. R., McManis, J. S., Dimova, H., Porter, C., Raisler, B. and Phanstiel, O. (1997) J. Med. Chem. 40, 1475-1494
18. Ha, H. C., Woster, P. M., Yager, J. D. and Casero, Jr., R. A. (1997) Proc. Natl. Acad. Sci. U.S.A. 94, 11557-11562
19. Mizzen, C. A. and Allis, C. D. (1998) Cell. Mol. Life Sci. 54, 6-20
20. Gu, W. and Roeder, R. G. (1997) Cell 90, 595-606
21. Waldman, T., Kinzler, K. W. and Vogelstein, B. (1995) Cancer Res. 55, 5187-5190
22. Waldman, T., Lengauer, D., Kinzler, K. W. and Vogelstein, B. (1996) Nature (London) 371, 713-716
23. Polyak, K., Waldman, T., He, T. C., Kinzler, K. W. and Vogelstein, B. (1996) Genes Dev. 10, 1945-1952
24. Wang, J. and Walsh, K. (1996) Science 273, 359-361
25. Gorospe, M., Cirielli, C., Wang, X., Seth, P., Capogrossi, M. and Holbrook, N.J. (1997) Oncogene 14, 929-935